Long terminal repeat U3 length polymorphism of human foamy virus

Virology

Volumn 230, Issue 2, 1997, Pages 167-178

  Schmidt, Martina ^a   Herchenröder, Ottmar ^b   Heeney, Jonathan ^c   Rethwilm, Axel ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; HAMSTER; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPUMA VIRUS; VIRUS CULTURE; VIRUS REPLICATION;

ANIMALIA; CRICETINAE; HUMAN FOAMY VIRUS; HUMAN SPUMARETROVIRUS; PAN (APE); SPUMAVIRUS;

EID: 18244417493     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8463     Document Type: Article

References (64)

1. Achong B. G., Mansell P. W. A., Epstein M. A., Clifford P. An unusual virus in cultures from a human nasopharyngeal carcinoma. J. Natl. Cancer Inst. 46:1971;299-307.
2. Ausubel F. M., Brent R., Kingston R. E., Moore D., Seidman J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1987;Wiley, New York.
3. Ball J. K., Diggelmann H., Dekaban G. A., Grossi G. F., Semmler R., Waight P. A., Fletcher R. F. Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus. J. Virol. 62:1988;2985-2993.
4. Bieniasz P. D., Rethwilm A., Pitman R., Daniel M. D., Chrystie I., McClure M. O. A comparative study of higher primate foamy viruses, including a new virus from a Gorilla. Virology. 207:1995;217-238.
5. Bigner D. D., Bigner S. H., Ponten J., Westermark B., Mahaley M. S., Ruoslahti E., Herschman H., Eng L. F., Wikstrand C. J. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropathol. Exp. Neurol. 40:1981;201-229.
6. de Celis J., Tobaly-Tapiero J., Hampe A., Emanoil-Ravier R. Structure and function of the long terminal repeat of the chimpanzee foamy virus isolates (SFV-6). Arch. Virol. 138:1994;345-355.
7. Enssle J., Jordan I., Mauer B., Rethwilm A. Foamy virus reverse transcriptase is expressed independently from the gag protein. Proc. Natl. Acad. Sci. USA. 93:1996;4137-4141.
8. Erlwein O., Rethwilm A. Bel-1 transactivator responsive sequences in the long terminal repeat of human foamy virus. Virology. 196:1993;156-168.
9. Fan H. Influences of the long terminal repeat on retrovirus pathogenicity. Sem. Virol. 1:1990;165-174.
10. Flügel R. M., Rethwilm A., Maurer B., Darai G. Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes. EMBO J. 6:1987;2077-2084.
11. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
12. Graham F., van der Eb A. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
13. Hall C. V., Jakob E., Ringold G., Lee F. Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J. Mol. Appl. Gen. 2:1983;101-109.
14. He F., Blair W. S., Fukushima J., Cullen B. R. The human foamy virus bel-1 transcription factor is a sequence specific DNA binding protein. J. Virol. 70:1996;3902-3908.
15. Herchenröder O., Renne R., Loncar D., Cobb E. K., Murthy K. K., Schneider J., Mergia A., Luciw P. A. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology. 201:1994;187-199.
16. Herchenröder O., Turek R., Neumann-Haefelin D., Rethwilm A., Schneider J. Infectious proviral clones of chimpanzee foamy virus (SFVcpz) generated by long PCR reveal close functional relatedness to human foamy virus. Virology. 214:1995;685-689.
17. Hsu C.-L. L., Fabritius C., Dudley J. Mouse mammary tumor virus proviruses in T-cell lymphoma lack a negative regulatory element in the long terminal repeat. J. Virol. 62:1988;4644-4652.
18. Kirchhoff F., Kestler H. W., Desrosiers R. C. Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene. J. Virol. 68:1994;2031-2037.
19. Kupiec J.-J., Kay A., Hayat M., Ravier R., Périès J., Galibert F. Sequence analysis of the simian foamy virus type 1 genome. Gene. 101:1991;185-194.
20. Lagaye S., Vexiau P., Morozov V., Guénebaut-Claudet V., Tobaly-Tapiero J., Cavinet M., Cathelineau G., Périès, Emanoil-Ravier R. Human spumaretrovirus-related sequences in the DNA of leukocytes from patients with Graves disease. Proc. Natl. Acad. Sci. USA. 89:1992;10070-10074.
21. Löchelt M., Flügel R. M. The molecular biology of human and primate spuma retroviruses. The Retroviridae. 1995;Plenum. p. 239-292.
22. Löchelt M., Muranyi W., Flügel R. M. Human foamy viruses genome possesses an internal, bel-1 dependent and functional promotor. Proc. Natl. Acad. Sci. USA. 90:1993;7317-7321.
23. Löchelt M., Zentgraf H., Flügel R. M. Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene. Virology. 184:1991;43-54.
24. Loh P. C., Achong B. C., Epstein M. A. Further biological properties of the human syncytial virus. Intervirology. 8:1977;204-217.
25. Mann D. L., O'Brien S. J., Gilbert D. A., Reid Y., Popovic M., Read-Connole E., Gallo R., Gazdar A. Origin of the HIV-susceptible human CD4+ cell line H9. AIDS Res. Hum. Retroviruses. 5:1989;253-255.
26. Maurer B., Bannert H., Darai G., Flügel R. M. Analysis of the primary strucutre of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J. Virol. 62:1988;1590-1597.
27. Maurer B., Serfling E., ter Meulen V., Rethwilm A. Transcription factor AP-1 modulates the activity of the human foamy virus long terminal repeat. J. Virol. 65:1991;6353-6357.
28. Michalides R., Wagenaar E. Site-specific rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in murine T-cell leukemias. Virology. 154:1986;76-84.
29. Michalides R., Wagenaar E., Weijers P. Rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in T-cell leukemias of mouse strain GR result in a novel enhancer-like structure. Mol. Cell. Biol. 5:1985;823-830.
30. Mikovits J. A., Hoffman P. M., Rethwilm A., Ruscetti F. W. In vitro infection of primary and retrovirus infected leukocytes by human foamy virus. J. Virol. 70:1996;2774-2780.
31. Moreau-Gachelin F. Spi-1/PU.1: an oncogene of the ets family. Biochim. Biophys. Acta. 1198:1994;149-163.
32. 60. Int. J. Cancer. 35:1985;275-280.
33. Neumann-Haefelin D., Fleps U., Renne R., Schweizer M. Foamy viruses. Intervirology. 35:1993;196-207.
34. Neumann-Haefelin D., Rethwilm A., Bauer G., Gudat F., zur Hausen H. Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells. Med. Microbiol. Immunol. 172:1983;75-86.
35. Norton P. A., Coffin J. Bacterial β-galactosidase as a marker of Rous sarcoma virus gene expression and replication. Mol. Cell. Biol. 5:1985;281-290.
36. Omer C. A., Pogue-Geile K., Guntaka R., Staskus K. A., Faras A. J. Involvement of directly repeated sequences in the generation of deletions of the avian sarcoma virus src gene. J. Virol. 47:1983;380-382.
37. Parthasarathi S., Varela-Echavarria A., Ron Y., Preston B. D., Dougherty J. P. Genetic rearrangements occuring during a single cycle of murine leukemia virus vector replication: characterization and implications. J. Virol. 69:1995;7991-8000.
38. Pathak V. K., Temin H. M. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: Deletions and deletions with insertions. Proc. Natl. Acad. Sci. USA. 87:1990;6024-6028.
39. Pulsinelli G. A., Temin H. M. Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer. J. Virol. 65:1992;4786-4797.
40. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector - new fast and versatile tools for detetion of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:1995;4878-4884.
41. Renne R., Friedl E., Schweizer M., Fleps U., Turek R., Neumann-Haefelin D. Genomic organization and expression of simian foamy virus type 3 (SFV-3). Virology. 186:1992;597-608.
42. Rethwilm A. Regulation of foamy virus gene expression. Curr. Topics Microbiol. Immunol. 193:1995;1-24.
43. Rethwilm A. Unexpected replication pathways of foamy virus. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 13:1996;S248-S253.
44. Rethwilm A., Baunach G., Netzer K. -O., Maurer B., Borisch B., ter Meulen V. Infectious DNA of the human spumaretrovirus. Nucleic Acids Res. 18:1990a;733-738.
45. Rethwilm A., Darai G., Rösen A., Maurer B., Flügel R. M. Molecular cloning of the genome of human spumaretrovirus. Gene. 59:1987;19-28.
46. Rethwilm A., Erlwein O., Baunach G., Maurer B., ter Meulen V. The transcriptional transactivator of human foamy virus maps to the bel1 genomic region. Proc. Natl. Acad. Sci. USA. 88:1991;941-945.
47. Rethwilm A., Mori K., Maurer B., ter Meulen V. Transacting transcriptional activation of human spumaretrovirus LTR in infected cells. Virology. 175:1990b;568-571.
48. Rösener M., Hahn H., Kranz M., Heeney J., Rethwilm A. Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis. J. Med. Virol. 48:1996;222-226.
49. Salahuddin S. Z., Markham P. D., Wong-Staal F., Franchini G., Kalyanaraman V. S., Gallo R. C. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology. 129:1983;51-64.
50. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor.
51. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
52. Schmidt M., Rethwilm A. Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology. 210:1995;167-178.
53. Schweizer M., Turek R., Hahn H., Schliephake A., Netzer K.- O., Eder G., Reinhardt M., Rethwilm A., Neumann-Haefelin D. Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: Appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res. Hum. Retroviruses. 11:1995;161-169.
54. Schweizer M., Turek R., Reinhardt M., Neumann-Haefelin D. Absence of foamy virus DNA in Graves' disease. AIDS Res. Hum. Retroviruses. 10:1994;601-605.
55. Spiro C., Li J.- P., Bestwick R. K., Kabat D. An enhancer sequence instability that diversifies the cell repertoire for expression of a murine leukemia virus. Virology. 164:1988;350-361.
56. Tamura N., Kira S. Human foamy virus and familial mediterranean fever in Japan. J. Am. Med. Assoc. 274:1995;1509.
57. Tong-Starksen S., Peterlin B. M. Mechanisms of retroviral transcriptional activation. Sem. Virol. 1:1990;215-227.
58. Varmus H. E. Form and function of retroviral proviruses. Science. 216:1982;812-816.
59. Varmus H. E., Brown P. Retroviruses. Berg D. E., Howe M. M. Mobile DNA. 1989;53-108 Am. Soc. Microbiol. Washington.
60. von Laer D., Neumann-Haefelin D., Heeney J. L., Schweizer M. Lymphocytes are the major reservoir for foamy viruses in peripheral blood. Virology. 1996.
61. Wasylyk B., Hahn S., Giovane A. The ets family of transcription factors. Eur. J. Biochem. 211:1993;7-18.
62. Weiss R. A. Foamy viruses bubble on. Nature. 380:1996;201.
63. Yu S., Baldwin D. N., Gwynn S. R., Yendapalli S., Linial N. L. The human foamy virus replication pathway is distinct from that of retroviruses and hepadnaviruses. Science. 271:1996a;1579-1582.
64. Yu S. F., Stone J., Linial M. L. Productive persistent infection of hematopoietic cells by human foamy virus. J. Virol. 70:1996b;1250-1254.